The Fly-In will feature a legislative briefing with former Rep. Jim McCrery, partner at Capitol Counsel, and a breakfast keynoted by Jayne O’Donnell, health care reporter for USA Today.
A partnership between HRA Pharma and Ibis Reproductive Health to begin an application for an OTC oral contraceptive to the Food and Drug Administration was recently announced, researchers noted.
Pharmacy patient care and collaboration across healthcare segments are vital to improving health and wellness nationwide, wrote Steve Anderson.
The Centers for Disease Control and Prevention recently collaborated with the Florida Department of Health to conduct additional analysis of locally acquired Zika cases, including analysis of resident travel patterns in Florida.
He served as senior advisor to President George W. Bush from 2000–2007 and as deputy chief of staff from 2004–2007.
Scott Gottlieb had served as a senior adviser at the Centers for Medicare and Medicaid Services during the Bush years and a decade ago served as a deputy commissioner at the FDA.
The ads state “Pharmacists provide access to better healthcare every day,” and “We’re here to provide access to health policy solutions.”
Of the three classes of medicine identified in the Canadian switch report, one is already available OTC in the U.S. and a second is expected to be under consideration for non-prescription status this year.
"NCPA believes these congressional committees should schedule hearings soon on S. 413 and H.R. 1038 to address this unsustainable situation," the association stated.
H.R. 749 is intended to require the U.S. Food and Drug Administration to act upon applications for generic drugs within 180 days of being filed that are in short supply or when there are too few manufacturers on the market is being revised.